ClinicalTrials.Veeva

Menu

Early Detection of Prostate Cancer of Syrian Men

A

Al-Hawash Private University

Status

Invitation-only

Conditions

the Detection of Prostate Cancer in Men

Treatments

Diagnostic Test: DRE
Diagnostic Test: PSA

Study type

Observational

Funder types

Other

Identifiers

NCT07075666
02-05-2025

Details and patient eligibility

About

Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.

Full description

This study aims to assess the awareness, attitudes, and practices regarding prostate cancer screening among men in the middle region of Syria, with the goal of identifying barriers to early detection and informing public health interventions.

Enrollment

1,000 estimated patients

Sex

Male

Ages

40 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men aged 40 years and older residing in the middle region of Syria.

Exclusion criteria

  • Men with a previous diagnosis of prostate cancer.

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems